
Given the prevalence of zzso bone disease in multiple myeloma zzso novel therapies targeting bone zzso are zzso Previous studies have identified zzso A to be of critical importance in zzso zzso zzso is a known and approved treatment strategy for relapsed zzso Our findings demonstrate that zzso acts directly on bone zzso zzso cells via an zzso increase in zzso zzso zzso signaling resulting in zzso A zzso with zzso zzso of zzso Here, we attempted to augment the zzso benefits of zzso while overcoming its effects on zzso by combining it with a zzso zzso to zzso zzso Increased zzso A zzso induced by zzso was zzso by the addition of zzso zzso zzso which effectively restored zzso function and inhibited zzso zzso without zzso the zzso effects of zzso on zzso zzso This provides the rationale for an ongoing clinical trial zzso combining zzso with an zzso A zzso 

